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SUMMARY 
We have begun a measured genotype approach to  the genetic analysis of lipid and lipoprotein 
variability. This approach enables one to simultaneously estimate the frequencies and effects 
of alleles a t  specific loci along with the residual polygenetic variance component. I n  this study 
we consider the contribution of three common alleles a t  the locus coding for apolipoprotein E 
to interindividual variation of total cholesterol, betalipoprotein, and triglyceride levels. A 
sample of 102 nuclear families consisting of 434 individuals was studied. The frequencies of the 
€2, €3, and €4 alleles in this sample are 0*137,0.740, and 0123, respectively. I n  separate analyses 
of cholesterol and betalipoprotein levels, a complete model that includes the effects of the six 
apo E genotypes, unmeasured polygenes, and individual specific environmental effects fits these 
data significantly better than a reduced model that does not include the effects of the apo E 
polymorphism or a reduced model that  does not include the effects of polygenes. On the average 
the €2 allele lowers total cholesterol and betalipoprotein levels by 0425 mmol/l and 0.81 1 units, 
respectively. The €4 allele is associated with an average increase of these phenotypes by 
0.255 mmol/l and 0.628 units, respectively. Simultaneous estimates of the interindividual 
variability of total cholesterol levels attributable to the apo E polymorphism and to residual 
polygenic effects are 8 % and 56 % , respectively. For betalipoprotein levels, we simultaneously 
estimate these values to be 7 yo and 42 Yo, respectively. A reduced model including the effects 
of polygenes but not the effects of the apo E polymorphism fitted the triglyceride data as well 
as the complete model. The estimate of the fraction of interindividual variability associated with 
polygenetic effects was 26.5 %. We review our present understanding of the genetic architecture 
underlying variability of cholesterol levels in the population a t  large and infer that the majority 
of the genetic variability may be accounted for by polymorphic gene loci with moderate effects 
on cholesterol levels. 
INTRODUCTION 
Biometrical genetic studies have established that a significant proportion of the interindi- 
vidual variability of many quantitative phenotypes is attributable to polygenetic differences 
among individuals. These studies assume that there are a large number of unlinked loci 
(polygenes) with small, independent and additive effects contributing to the phenotype of 
interest. This assumption has often been accepted as a biological fact. Findings from limited 
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experimental animal work suggest that  this assumption may not be valid, at least for some traits 
(Thompson, 1975; Thompson & Thoday, 1979; Hopkinson et al. 1964). Their work suggests that  
relatively few gene loci may be responsible for the genetic component of quantitative phenotypic 
variability. Direct estimation of the frequencies and effects of alleles a t  specific loci is required 
to elucidate the genetic architecture (number of loci, frequency of their alleles, size of their effects 
and type of loci) of a quantitative phenotype. 
In order to investigate the frequencies, effects, and the contribution to phenotypic and 
polygenetic variance of a specific locus, we have implemented a ‘ measured genotype ’ approach 
to the genetic analysis of a quantitative phenotype (Boerwinkle et al. 1986~) .  This approach 
uses measured genetic variability a t  loci that are physiologically involved in the determination 
of a quantitative phenotype. Lipid metabolism is a system that allows one to  pursue a measured 
genotype approach to genetic variability. Biometrical genetic studies have demonstrated that 
a significant proportion of the variability of many lipid and lipoprotein phenotypes in the 
population a t  large is attributable to genetic differences among individuals (Sing & Orr, 1978; 
Rao et a1 1979). Applications of this approach by ourselves (Sing & Davignon, 1985; Boerwinkle 
et al. 19863) and others (Uterman et al. 1979; Robertson & Cumming, 1985), have utilized 
samples of unrelated individuals and primarily investigated the frequencies and effects of alleles 
at only the. measured locus. 
By sampling groups of related individuals and measuring the value of a quantitative 
phenotype and the genotype at  a single locus, one can directly partition the overall genetic 
variability into a proportion attributable to the measured single locus and a proportion due to 
the segregation of unmeasured residual polygenes. The logic and methods that enable one to 
simultaneously estimate the frequencies and effects of the alleles at a single measured locus, 
and a residual polygenetic variance component, have been presented in the first paper in this 
series (Boerwinkle et al. 1 9 8 6 ~ ) .  In  this paper, we simultaneously estimate the frequencies and 
effects of a single measured locus, and the residual polygenetic variance in order to begin 
to investigate the role of the apolipoprotein (apo) E polymorphism in determining the genetic 
architecture underlying quantitative phenotypic variability in three measures of lipid 
metabolism. 
Many of the phenotypes that are measures of lipid metabolism, such as total serum cholesterol 
levels. are associated with one’s relative risk of coronary artery disease (Davignon et al. 1983). 
Genetic loci involved in lipid metabolism have been identified and allelic variability a t  many 
of these loci has been described (reviewed in Breslow, 1985). I n  this study we are continuing 
our efforts to  understand the genetic variability underlying lipid and lipoprotein quantitative 
phenotypes. We have measured total cholesterol, betalipoprotein and triglyceride levels, and 
scored the apo E polymorphism on a sample of 102 nuclear families consisting of 434 individuals. 
Apo E has an important role in lipid metabolism as a structural component of VLDL, a ligand 
for lipoprotein receptors and is involved in the conversion of VLDL to LDL by lipoprotein 
lipase. Apo E is also polymorphic (Ctermann et al. 1977; Zannis & Breslow, 1981; Bouthillier 
P t  al 1983). There are three common isoforms of apo E designated E2, E3 and E4 which are 
distinguishable by isoelectric focusing. The three alleles that  code for these isoforms combine 
to produce six possible genotypes (€212, €213, €214, €313, €314 and €414).  We wish to investigate 
the contribution of the apo E polymorphism to the determination of the polygenetic variability 
of cholesterol. betalipoprotein and triglyceride levels. These analyses are the first efforts to 
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directly partition the contribution of a single polymorphic locus out of the polygenetic variance 
for these quantitative phenotypes. 
METHODS 
Samples considered 
The analyses reported here were carried out on a sample of 102 nuclear families obtained as 
part of a large population based preventive medicine study in Nancy, France (Houot et al. 
1985). The families were sequentially sampled a t  the Centre for Preventive Medicine in Nancy 
between August 20, 1983 and September 12, 1983. These 102 families consist of 434 individuals 
(204 parents and 230 children). Only criteria that  do not allow routine phlebotomy were reasons 
for exclusion. There are no individuals in this sample recorded as using antihyperlipidemic 
drugs. To compare adults and children for the effects of the apo E polymorphism on lipid and 
lipoprotein variability, the 204 parents and the youngest child from each family were considered. 
Laboratory procedures 
Blood was collected into heparin containing tubes between 8.00 a.m. and 9.00 a.m. or between 
11.45 a.m. and 12.45 p.m. from fasting and supine individuals. Total plasma cholesterol was 
measured enzymatically on an SMA (Technicon) by the method of Allain et al. (1974); 
triglycerides were measured enzymatically on a GSA I1 (Greiner) by the method of Steinmetz 
& Panek (1978). Betalipoprotein levels were measured using a turbidimetric method (Burstein 
& Samaille, 1959). This method estimates lipid and lipoprotein components of LDL and VLDL, 
which are reported in relative units of absorbance. 
A 2 ml aliquot of plasma from each subject was sent to  Ann Arbor on dry ice for typing the 
apo E polymorphism by two-dimensional gel electrophoresis. Plasma samples were kept a t  
-80 "C until they were electrophoresed. Two microlitres of plasma were used for each 
two-dimensional gel. The two-dimensional electrophoresis was carried out as previously described 
(Nee1 et al. 1984; Boerwinkle et al. 1986b). First-dimension electrophoresis utilized ampholytes 
(LKB) with a pH range of 3.5 to 10 and was carried out for 15 h a t  1200 V and 2 h a t  1500 V. 
The slab gels contained a 110-130 g/1 acrylamide gradient. Following electrophoresis, the gels 
were intially stained with Coomassie brilliant blue and then were subsequently silver stained 
by the method of Sammons et al. (1981). The three isoforms of apo E appear as separate spots 
on the gel. The two-dimensional electrophoretograms reported here were typed concordantly 
and independently by two experienced observers. Typing of a gel was done without knowledge 
of the individual's lipid and lipoprotein levels, or the apo E type of his or her relatives. 
Statistical methods 
Before investigating the effects of the apo E polymorphism on the lipid and lipoprotein 
phenotypes, multiple linear regression was used to adjust these traits for the effects of variation 
in gender, generation, hormone use in women, age within generation, height and weight. The 
model and analytical methods for estimating from pedigree data the frequencies and effects of 
the apo E polymorphism, the polygenetic variance component, and a nongenetic variance 
component were given in the first paper of this series (Boerwinkle et al. 1 9 8 6 ~ ) .  Briefly, we model 
the adjusted lipid or lipoprotein level of the ith individuals as 
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where p, is the mean of the j t h  genotype at a single locus, Gi is the deviation from pj due to 
the polygenotype of the ith individual, and Ei is the deviation from pj due to totality of all 
environmental effects and measurement errors specific to the ith individual. The polygenotype 
is assumed to be determined by a large number of unlinked loci each with small additive allelic 
effects that combine independently and additively. G and E are random effects that are assumed 
to be independent and normally distributed, each with a mean of zero and variance a& and af, 
respectively. The likelihood of observing the measured single locus genotypes and phenotypes 
of a family can be partitioned into the likelihood of observing the measured genotypes times 
the likelihood of the phenotypes of the family members conditional on their measured single 
locus genotypes. The likelihood of the measured single locus genotypes is a simple function of 
the genotype or allele frequencies of the measured locus and Mendelian transmission pro- 
babilities. The likelihood of the phenotypes of the members of a family, conditional on their 
measured single locus genotypes, is a multivariate normal distribution with mean vector p and 
covariance matrix Z. The mean vector takes the value of the genotypic means determined by 
the measured genotype of the family members. The elements of I2 are a function of the variance 
components of the model and the coefficient of relatedness between individuals (Boerwinkle et 
0 1 .  1 9 8 6 ~ ) .  Thc parameters of the model to  be estimated include the genotype frequencies for 
the measured single locus U;), the genotype specific means (pj ) ,  the polygenetic variance 
component (n2,). and a variance component due to individual specific non-genetic effects (nk). 
Estirnatcs of the allrlc frequencies were obtained by allele counting using the measured 
genotypes of the parents. Estimates of the means and variance components were obtained using 
Fisher’s scoring algorithm and the derivatives given previously (Boerwinkle et al. 1 9 8 6 ~ ) .  To 
cvaluate the precision of the parameter estimates in one case, we also present the estimated 
varianc~~-covariance matrix of the parameter estimates for our analysis of total plasma 
cholcstcrol levds. Thc elements of this matrix are the elements of the negative of the inverse 
of the information matrix evaluated a t  the maximum likelihood estimates of the parameters 
of the. model. 
Hypothesis tcsting was carried out  by comparing complete and reduced models. Parameter- 
ization of the complete model includes the frequencies and means of the six apo E genotypes, 
r:; and CT;. Keduced models were generated from the complete model by fixing one or more 
parameters to hypot hesized values. The test statistic used to compare competing hypotheses 
is equal to - 2 ( L R - L c )  H here L ,  is the maximum log, likelihood of the complete model and L,  is 
the maximum log, likelihood of the reduced model. The likelihood ratio statistic is distributed 
approximately as a chi-square with degrees of freedom determined by the number of parameters 
mnstraincd in the reduced model. Reduced models of specific interest here are: (1) the apo E 
polymorphism has no effect on lipid and lipoprotein levels; (2) the residual polygenetic variance 
component is (qua1 to zero: and (3) a subset of the apo E genotype specific means are equal 
to one another. The subsets of means set equal to  one another were chosen based on the results 
of previous analyses on the effects of the apo E polymorphism on these and other phenotypes 
(Menzrl P t  al. 1983. Robertson & Cumming. 1985; Sing & Davignon, 1985; Boerwinkle et al. 
19X6b j From these studies, we hypothesize that the mean cholesterol and betalipoprotein levels 
of individuals with the sZ/Z  and c 2 / 3  genotypes were equal to one another, as are the mean 
levclh of individuals ~ i t h  the d / 4 ,  e3 /4  and e 4 / 4  genotypes. No a priori hypotheses were 
formulated about the effects of the apo E polymorphism on triglyceride levels. 
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Table 1. Phenotypic means and (standard deviations) for each type of family member and the relative 
frequencies of their apo E genotypes 
































































































Four methods were used to estimate the contribution of the apo E polymorphism to the 
phenotypic and polygenetic variance. The expected contribution of the apo E polymorphism 
to the phenotypic variance in the population a t  large is 
where j indicates the j t h  apo E genotype and p.  = E fj pj.  Hence the variance of the phenotype 
in the population is equal to 
V(Y(j)  = c fj(pj-p.)"+;++&. (3) 
The first method of estimating the variance contribution that we considered simply substitutes 
parameters of the model in equation (2) with parameter estimates. This estimator is biased 
(Boerwinkle & Sing, 1986). It will, on the average, overestimate the variance contribution of 
the single measured locus. For a sample of unrelated individuals, the bias correction is equal 
to ( ( J - l ) / n ) ( a L  +a&)), where J is the number of genotype classes and n is the number of unrelated 
individuals in the sample. For a sample of related individuals, the expectation of the magnitude 
of the bias has not been derived. We took two approaches in formulating a bias corrected 
estimator. We set n equal to the number of parents in the sample (the second method) and also 
set n equal to the total sample size (the third method). The fourth method considered estimates 
the variance contribution of the single locus by the increase in the estimated polygenetic 
variance component when the measured single locus effects are not parameterized in the model 
over the estimated variance component when the measured single locus effects are included in 
the model. 
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Table 2 .  .tfaxirnum likelihood estimates of parameters of selected models 
('l'ht, iplntit e lop, likelihood for each model and tests of hypotheses are also given ) 
Models 
PZZ = p23 
P 3 3  So apo E 
( 'omplete effect a; = 0 P2a  = P34 = PM 
Cholesterol 
P S 2  4'7 1 5.38 4.84 4'94 
t ( 2 3  494 5.38 494  494  
"33 5.46 5.38 5'43 5'45 
P 21 5.28 5.38 5'33 5.62 
"34 5.65 5.38 5.62 5.62 
P 11 5'9 1 5.38 5'97 5'62 
ff ;. 0.309 0.324 0.732 0.31 I 
.:; 0.399 0.448 (0.00) 0.403 
0.563 0.580 (0.00) 0.564 
log, - 520.61 - 537'77 - 549'29 - 522'25 
- 3.28( NS) 
p 2 1  34'32** 57.36** 




r 2 2  5.85 7'1 I 5'92 6.27 
/ l 2 3  6.26 7'1 I 6.3 I 6.27 
P 3 3  7'23 7'1 I 7'17 7.22 
P Z 4  7.0 I 7'1 I 7.16 7'64 
P3.1 7.68 7.1 I 7.63 7'64 
P 4 4  8.87 7.1 I 8.92 7'64 
4 1.91 2.03 3'34 1.93 
ff; 1'41 "54 (0.00) 1'42 
h2[ll 0'42 0.43 (0.00) 0.42 
likrlihood 
I(%, - 865.70 - 880.97 - 879.85 - 867.87 
- 30'54** 28.30** 4 3 4 ( W  X2L21 
((1.f.j (5) (1)  (3) 
Triglycerides 
1/22  "324 0.885 1.318 
P 2 3  0.892 0,885 0.898 
/ I 3 3  0.862 0.885 0.860 
P 3 r  0.894 0,885 0.889 
1'24 1'05 I 0885 1.034 
1144 I ,046 0.885 1'04.4 
ff:; 0.053 0.0546 (0.00) 
h2l I1  0.262 0.265 (0.00) 
xZ121 - 5,66(SS) 12.98** 
f;: 0'1 50 0'1 51 0.204 
I(%', - 265'47 - 268.30 -271'96 
1 ikel ihootl 
(d.f. j (5 )  (1)  
0-;; 
CT; + CT2' 111 hL = __ 
"1 ,y2 = -2(log, ((lomplt=tr)-logc (Reduced)) ( ) indicates fixed in model to hypothesized value. 
* P < 0.05. t' < 0.01 
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RESULTS 
Descriptive statistics for the family members are given in Table 1. One 'family' had no 
children and the other families had an average of 2.28 children per family. As expected, the 
fathers of these nuclear families were older, taller, heavier, and had higher lipid and lipoprotein 
levels than their spouses. The mcan levels of the measured concomitants. and lipid and 
lipoprotein phenotypes were higher for parents than for children. For children, the mean levels 
of the measured concomitants and the lipid and lipoprotein phenotypes were comparable 
bctmeen genders 35 o/o of the interindividual variability in plasma cholesterol levels in this 
sarriplc could be accounted for by a linear relationship with generation, gender, hormone use 
among females, age, height and weight. This value is 41 74 and 24% for betalipoprotein and 
triglj cerides, respectively. Adjustment by linear regression for variation in these concomitant 
variables results in a statistically significant ( P  < 0.01) reduction in variance for each of the 
three phenotypes. 
Thc relative frequencies of the six apo E genotypes for each gender by generation group are 
also given in Table 1. These relative frequencies are not significantly heterogeneous among these 
groups. lrsing the genotype counts from the parents, the estimated relative frequencies of the 
62. e 3  and €4 alleles in the population at, large are0.137 (k0*00029), 0-740 (k0.00098) and 0.123 
(+OW080), respectively. The relative frequencies of the €2, €3 and €4 alleles in the children 
are 0.1 11 (i0*00022), 0761 (&000089 and 0.128 (+000077), respectively. The genotype 
counts of the parcnts and the children do not differ significantly from those expected assuming 
Hardy-M'einberg equilibrium. Using a chi-square goodness-of-fit test (Vogel & Motulsky, 1979), 
the wgregation of the apo E genotypes among the children in the families does not differ 
significantly from the ratios expected under a model of autosomal codominant inheritance N ith 
Mendelian segregation probabilities. 
The maximum likelihood estimates of the apo E genotype specific means, the polygenetic 
variance component, and the individual specific environmental variance component for various 
modcls are given in Table 2. Table 2 also presents the log, likelihood of the parameter estimates 
of t h e  model given the quantitative phenotypes and the apo E genotypes and the difference 
bcitwcen the log, likelihood of the complete model and each of the reduced models. 
For total plasma cholesterol levels, the complete model fitted the data significantly better 
than a model with no polygenes ( P  < 0.01) and a model with no effect of the upo E polymorphism 
( P <  0.01). The rrduced model that groups genotype specific means based on a priori 
hypotheses. fitted the data as well as the complete model. Individuals with the E2/2 genotype 
had the lowest average cholesterol in the sample and individuals with the €414 genotype had 
the highest average cholesterol in the sample. Individuals with apo E genotypes e2/2  and ~ 2 / 3  
had lower average cholesterol levels than the grand mean, and individuals with apo E genotypes 
~ 2 / 1 ,  ~ 3 / 4  and ~ 4 / 4  had higher average cholesterol levels than the grand mean. €313 individuals 
had an average cholesterol level close to  the grand mean. For the complete model, 56 0,; of the 
phenotypic variance within apo E genotype class was attributable to residual polygenetic effects. 
M'hen there was no apo E effect parameterized in the model, the polygenetic variance 
contribution to the variance of cholesterol levels was 58 yo. 
The complete model describing the distribution of betalipoprotein levels also fitted these data 
significantly better than a model with no polygenes ( P  < O O l ) ,  significantly better than a model 
15 2 
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Tablc 3 .  I'ariunce. covariance and correlation matrix of the parameter estimates of the full model 
fo r  our analysis of cholesterol levels 
(The variances of the parameter estimates are on the diagonal of the matrix, the covariances between 
the parameter estimates are in the lower triangle of the matrix and the correlations between the 
pwarwter estirnatw are in the upper triangle of the matrix.) 
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with no effect of the tcpo E polymorphism (P < 0.01), but not significantly better than the 
reduced model based on a priori results of the effects of the apo E polymorphism on 
betalipoprotein levels. Individuals with the s2 /2  and e 4 / 4  genotypes have the lowest and highest 
averagc beta1ii)oprotcin levels, respectively. As for cholesterol, individuals carrying 
an 62 allele tended to have lower betalipoprotein levels than the grand mean, and individuals 
carrying an €4 allele tended to have higher betalipoprotein levels than the grand mean. 42 yo 
of the betalipoprotein variance within up0 E genotype class was attributable to residual 
polygenetic eflwts. 
For triglyceridc>s, thc complete model predicts that individuals carrying an €3 allele have lower 
triglycwide levels than individuals not carrying an €3 allele. 26 yo of the within apo E genotype 
phenotjvpe variance can be accounted for by the effects of residual polygenes. The complete 
niodel tiescribing the distribution of triglyceride levels among family members did not fit the 
data Significantly better than a model with no apo E effects, but significantly better than a model 
with no polygenes. Assuming no effects of the apo E polymorphism, a model with polygenes 
fitted these data significantly better than a model without polygenes (data not shown; x2 
( 1  c1.f.) = 12.86. i' < 0.01). These data predict that the up0 E polymorphism has no statistically 
signifimnt effect on triglyceride levels and that 26.5 O 0  of the variability of plasma triglyceride 
Thc estimated variances, covariances and correlations of, and between, the parameter 
estiniatc~ of the completcl model for our analysis of cholesterol levels are given in Table 3. The 
average magnitude of the standard deviation of the estimates of the single locus genotype means 
is on]) 0.181. JItlasuretl genotype analyses typically yield smaller variances of the parameter 
estimates than unmeasured genotype analyses, such as complex segregation analysis (Boer- 
winkle. 1985). The variances of the variance component estimates are also small. The covariances 
and wrwlations between the estimated genotype specific means and variance components are 
ZCI'O hwause ofthc h1oc.k diagonal structure of the information matrix (Boerwinkle et al. 1 9 8 6 ~ ) .  
'I'hc c.orrc.lations betu cen the estimates of the genotype specific means are all positive and low. 
T h r  c*orr.clation bet\\ cen the estimates of the residual polygenetic and individual specific 
nongcirit,tic. varianw components is negative and quite large. We attribute this to a fixed within 
up0 E yenotyp(~ phrnotypic variance in the sample that can be partitioned into the two variance 
IS attributable to polygenetic differences among individuals. 
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Table 4. Estimates of the contribution of the apo E polymorphism to the genetic and phenotypic 
variance 
Var (apo E) 
Var (apo E) + u; 
Var (apo E) 
Var (apo E ) + u& + uH Method 
Cholesterol 
Var (apo E) 
zf j (Pj -P. )2 0.0690 0' I47 0088 
C f j ( P j - P Y  0.05 I 6 0.114 0068 
- ( ( J -  l)/n*)(u& + ub) 
- ( ( J - l ) /n t ) (4+&) 
X.fj(Pj -P.Y 00608 0 1 3 2  0079 
u;,- u&S 0'0490 0109 0.065 
W j ( P j  -P.Y 0.290 0.171 0080 
Betalipoprotein 
Cf j (P j  -P.Y 0.209 0129 0059 
- ( ( J -  1 ) /n* ) (  u& + UH) 
- ( ( J - l ) /n t ) (U;+4 
z f j (P j -P . )2  0252 0'152 0.070 
U&' - u&$ 0.13 0.084 0038 
Trigly ceride 
V j ( P j - P . ) *  0'0052 0.089 00250 
q ( P j - P . ) z  00002 00038 000 I 0  
- ( ( J -  l)/n*)(u;+ag) 
- ( ( J - l ) / n t ) ( 4 + 4 )  
zf j (Pj-P.)*  0~0029 00519 0.0141 
u& - u g  0.0030 0.054 0.0 I 46 
* n = 204 
t n = 434 
$ u& is the polygenetic variance component in a model that does not parameterize the measured genotype 
information. 
components. The sum of the two variance components is fixed for this sample - so, if one goes 
up, the other must go down. 
The contribution of the apo E polymorphism to the variance of cholesterol, betalipoprotein 
and triglyceride levels is given in Table 4. This contribution has been estimated using four 
different estimators : substituting parameters in equation (2) with parameter estimates, two bias 
corrected estimators, and the difference between the estimated polygenetic variance Components 
of the complete model and a model with no apo E effects parameterized. The proportion of the 
estimated genetic variance and phenotypic variance attributable to the apo E polymorphism 
estimated by each method are also given. The contribution of the apo E polymorphism to 
variability of cholesterol levels ranges from 65 yo to 8.8 yo, depending on the method used. We 
estimate that this polymorphism accounts for between 10.9 % and 14.7 yo of the genetic variance 
underlying cholesterol variability, depending on the method used. The apo E polymorphism 
accounts for between 3-8 yo and 8 %, and between 0.1 yo and 2.5% of the variability of 
betalipoprotein and triglyceride levels, respectively. No other loci have been identified with such 
a large contribution to the interindividual variability of a cardiovascular disease risk factor in 
the population a t  large. 
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Total Plasma Betalipoprotein Triglycerides 
Cholesterol (absorbance) ( mm o I/L) 
(m m o I/ L) 
o.8 T €4 
0.6 - -  
0.4 - -  
-0 .6  .. 
- 0 . 8  T 
-0.81 1 
Fig 1 Arrrape rffect. of the  npo E allelrs 
- 1  0 
uIscI~ssIos 
IT\ing nit~asurc~d pt.iiotyp(’ analyses of data from 434 individuals from 102 nuclear families, 
V P  ha\.(’ siniultant~ously cstirnatecl the frequency and effects of the apo h’ polymorphism, and 
thcl rcwlual I)olj-pcvic.tic (~ffwts on quantitative ltvcls of total plasma cholesterol, betalipo- 
1)rotc.i ti- and triglywrides Individuals n i t h  the e2/2 arid a2/3 genotypes had lower average 
c~hol(~~tr~ro1 and ~ ~ t ~ t a l i ~ ~ o ~ ~ r o t e i ~ i  Icrels than the grand mean and individuals with the e3 /4  and 
f,4/4 pr.notj.pc.5 had h ighc~  a \  eragr cholesterol and betalipoprotein levels than the grand mean. 
I n  ytwarai, t h c  frc.qiwn(.y and d fwts  of the  rrpo E polymorphism reported here are in accordance 
tilts of others (revie\\cd in Sing 8: Davignon. 1985; Boerwinkle ~t al. 19866). The 
rcsidual polj gc>netic. \ urianw accounts for 56” and 42 O 0  of the within apo E genotype variance 
of c*holt~stcw)l and hvt alipoprotcins. respecstivcly. So effect of the apo E polymorphism on 
triglyc.c~ritlc lex els M a. cletc.cAtcd. Vnmeasurctl polygenetic differences among individuals ac- 
cwunt for  26.5 0 o  of the intcrindividual variability of triglyceride levels. 
\Vit  ti the rwi l t s  1)rewntetl here. ~e have begun to investigate the genetic architecture 
unt1erl.i ing csholrsterol bctalipoprotein and triglyceride variability. Using the estimated allele 
frcquc.nc*ics and the wtiinatetl genotype specific phenotypic means, we next calculated the 
avcrayr’ d k c t s  of the upo h’ alleles on total cholcsterol. betalipoprotein and triglyceride levels 
(Fig. 1 )  E’ormalac~ for estimating the averagcb effects of the apo E alleles have been previously 
prrsentd (Sing K. Ilavignon. 1985: Boer\$ inkle et n l .  19866). The average effect of an apo E allele 
niay hc intcryrcbtcd as the avc’rage deviation from the sample mean of individuals carrying that 
allrlc Thc avc.ragt. effect of the €2 allele is to loacr cholesterol and betalipoprotein levels by 
0,425 ~nmol/l and 0.81 1 units. respectively. The average effect of the e4 allele is to raise the level 
of thew phenotypes t)! 0.235 mmol/l and 0.628 units, respectively. The average effect of the 
6,’s wll r l ( .  IS near zer 1. Tht. average effects of the npo E alleles on triglyceride levels are also near 
zcro. ‘I’htw avc.ri*gc tfkcts of the npo h’ alleles are similar to those reported for other populations 
(reviewed in Boerwinkle rt nl. 19866). 
Tht. model given in equation (1) assumes that the average effects of an apo E allele are the 
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same for all individuals carrying that allele. Our previous analyses have indicated that there 
is no evidence for statistically significant interaction between the effects of the apo E 
polymorphism and the effects of gender (Boerwinkle et al. 1986b). The results reported here are 
the first time that the frequency and effects of the apo E polymorphism have been examined 
in a sample including children. We examine here whether the effects of the apo E polymorphism 
on total cholesterol levels are consistent between generations. To do this, we created two 
subsamples to compare. The first subsample consists of the parents of the families ( N  = 204) 
and the second subsample consists of the youngest child from each family ( N  = 101 ; recall that 
one ‘family’ was childless). Among the sample of parents, the average effects of the €2, €3 and 
€4 alleles are -0.54 mmoljl, 0.06 mmol/l and 0-24 mmol/l, respectively. Among the sample of 
children, the average effects of these alleles are -0*67,0*06 and 0.31 mmol/l, respectively. The 
distributional properties of the estimated vector of average effects of alleles are unknown and 
a method for testing the equality of a vector of average effects of alleles is not obvious. We used 
a sample-resample method, described in the appendix, to test the hypothesis that the average 
effects of the apo E alleles are equal between generations. We infer that the average effects of 
the apo E alleles are not statistically different between the parents and the youngest child of 
the families. 
The variability among estimates of the contribution of the apo E polymorphism to the 
phenotypic variance presented in Table 4 is not large. For total plasma cholesterol levels, the 
contribution of the apo E polymorphism to the phenotypic variance ranged from 6.5 % to 8.8 yo. 
It is not clear which estimator is more accurate. We know that the estimator derived directly 
from the parametric definition given in equation (2) is biased upward (Boerwinkle & Sing, 1986). 
The two bias corrections applied here are intuitive and may not be the correct magnitude. The 
form of the bias correction is based on the bias correction appropriate for a sample of unrelated 
individuals (Boerwinkle & Sing, 1986). The estimator based on the difference between 
polygenetic variance components may also be biased. Clearly, the problem of estimating the 
contribution of a single polymorphic locus to the determination of the polygenetic variance has 
yet to be adequately resolved. 
One advantage of the measured genotype approach to quantitative phenotypic variability 
is that it creates a more complete picture of the sources of genetic variability contributing to 
the phenotype. A measured genotype approach yields critical information for elucidating the 
genetic architecture of quantitative phenotypic variability. Below, we summarize our 
understanding about the genetic architecture of total cholesterol variability. This understanding 
is developed from the work presented here, in the other papers in this series, and by the work 
of others. Ignoring the measured genotype information, we report here that 58% of the 
interindividual variability in adjusted cholesterol levels is attributable to genetic differences 
among individuals. This number is similar to that reported by others (Sing & Orr, 1978; Rao 
et al. 1979). It is the goal of a measured genotype approach to partition this polygenetic variance 
contribution into the contribution of individual measured loci and residual unmeasured 
polygenes. In  the present study, we estimate that about 7 yo of the variability of cholesterol 
levels among individuals is attributable to the apo E polymorphism. We also estimate that 56 74 
of the within apo E genotype cholesterol variability is attributable to residual polygenetic 
effects. I n  earlier studies (Boerwinkle et al. 1986b; Boerwinkle et al. 1987) using samples of 
unrelated adults, we reported that the apo E and apo A-I V polymorphisms account for 8.6 yo 
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and 0.6 ",. respectively, of the interindividual variability in adjusted total cholesterol levels. 
Talmud & Huniphries (1986) described an Xba I restriction fragment length polymorphism in 
the apo H gene that accounts for 18 "lo of the cholesterol variability in a sample of 61 individuals 
from London. Moll et al. (1986) have reported evidence from segregation analysis of the existence 
of a polymorphic locus with a major effect on apolipoprotein A-I levels that  accounts for 1 Yo 
of thc variance of (.holesterol levels. Sing & Orr (1976) identified 4 polymorphic blood markers 
(Gm. hnptoylobin. S e  and BBO) that  had a small but significant contribution (about I %) to the 
interindividual variability of cholesterol levels among 6366 individuals from Tecumseh, 
J l ich~pan.  (4cne.t ic variability at  the LDL receptor locus (Goldstein & Brown, 1979) accounts 
than 1 O 0  of tht, (aholesterol variability in the general population (Sing et al. 1975). This 
is not a cwmpletv list. Thcrc are likely other polymorphic loci whose products are involved in 
lipid metabolism. the t>ffects of which are not considered here. Assuming that there is no 
statisticd interaction hetween the effects of these loci, the combined contribution of these loci 
to the Interindividual variability of cholesterol levels is approximately 34 yo. 
&At Icast tmo major points emerge from these studies. The first major point is that  if the results 
reviekt t h d  here give any indication of future directions, as more measured genotype analyses are 
caarricti out on a gircn phenotype. the sum of the contributions of individual loci to the 
phcnot? pic. variance may exceed the polygenetic variance component. The few loci discussed 
above  account for approximately 34 9, of the phenotypic variance for total serum cholesterol 
1evc.h A4ssuniing that 5 8 O ,  of the phenotypic variance can be accounted for by polygenetic 
among individuals, these loci account for 59 yo of the polygenetic variance. If the 
other l o c i  have a contribution similar to the apo E and up0 A-IF' polymorphisms, i t  will only 
requirt. four or  five more to account for all the genetic variability underlying cholesterol 
variability. HOES can this be so in light of the fact that  there are likely many loci affecting 
cholesterol levelh IVv bclieve there arc four likely explanations. The first is that  the samples 
revicmcrl abovv are hPterogeneous in such a way that the results cannot be pooled across studies. 
Although thia is likely the case, we believe that these few loci are still contributing to a very 
large fraction of thc plygenetic variance component. The second explanation is that  the loci 
are interacting in  such a way that  the variance contribution by multiple loci is less than the 
sum of the variance contributions of individual loci. In  preliminary analyses of 188 unrelated 
individuals measured for the apo E polymorphism, apo A-Z V polymorphism, and plasma levels 
of cholesterol. bt.talipoprotein and triglycerides, we have detected no significant evidence for 
statistical interaction between the effects of these loci on the levels of these quantitative 
phmotypes (Hot.rwinklc & Sing, unpublished results). This does not preclude interaction 
between other 1oc.i. The third explanation is that  the loci with moderate and large effects have 
all h c ~ n  accountcd for and the remaining loci have very small contributions to the phenotypic 
varianw. The fourth explanation is that  our methods of estimating the variance contribution 
of a single measured locus and the polygenetic variance component are incorrect and/or not 
comparable. Th(1 variance contribution of the single measured locus is calculated from its 
genotype frequencies and effects. The polygenetic variance component is a random effect 
estimated as a function of the covariance between relatives. The polygenetic model assumes 
there arc a largc number of unlinked loci, each with small effects so that, by the central limit 
t heortm. the polygenetic effects are normally distributed in the population with variance u:. 
Thc variance contribution by loci such as apo E is relatively large. How loci with large (fixed) 
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effects contribute to the polygenetic (random) effects is not clear. By the very nature and 
assumptions of the traditional polygenetic model, it  may ‘not allow’ one to partition out of 
the estimated polygenetic variance component the effects of individual loci with large 
contributions to the variance of the quantitative phenotype. 
The second major point is that the majority of the genetic variability can be accounted for 
by polymorphic gene loci with moderate effects on the quantitative phenotype. The contribution 
to cholesterol variability by genes marked by ABO and other marker loci (Sing & Orr, 1976) 
is small because of their minuscule effects. Loci with very large effects on the individual, such 
as familial hypercholesterolemia and its effect on cholesterol levels (Goldstein & Brown, 1979), 
for example, do not contribute greatly to the phenotypic variance in the population because 
of the rare frequency of the variant genotype. It is relevant for a discussion of the genetic 
architecture of a quantitative phenotype to distinguish between the relationship that exists 
between the effect o fa  single locus on the level of the phenotype for an individual and the effect 
of the locus on the variance of the phenotype in the population a t  large. We hypothesize that 
polymorphic loci in the population that have moderate effects on the level of the phenotype 
of an individual contribute to the majority of the genetic variance in the population. 
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APPENDIX 
HypothPsis Testing f o r  the Aaerage Effects of Alleles Among Groups 
Thc average effect of an allele may be interpreted as the expected deviation from the 
population mean of an individual carrying that allele. Nost textbooks of quantitative genetics 
prescnt expressions for the average effects of alleles as a function of the genotype frequencies 
and phcnotype value (see for example, Kempthorne, 1969; Falconer, 1981). In  this paper, we 
calculate the average effect of the three up0 E alleles on total plasma cholesterol, betalipoprotein 
and trigly-ceride levels. The formula used here for estimating the average effect of an allele is 
equal to  
\+hr.r<> zl is the average cffcct of the j t h  allele, i are the other alleles a t  the locus, ,uij is the mean 
phcnotj.pic* lcvel of the ijth genotype. p. is the grand mean,ftj is the expected frequency of the 
i j th y t ~ n o t y p  assuming Hardy-IVeinberg equilibrium and f, is the allele frequency of the j t h  
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Fig. 2 .  Frequency distribution of g(a) for total cholesterol levels over 5000 permutations of the data 
allele. For a given genetic system there are as many average effects of alleles as there are alleles 
at  that locus. The average effects of alleles at a locus are subject to the restriction : Cfj aj = 0. 
The statistical properties of the estimated average effects are not known. They are complicated 
functions of the estimated allele frequencies and genotype means. A method for testing 
hypotheses about the value of the average effects of alleles at a locus, or the equality of the 
average effects of the alleles a t  a locus among groups is not obvious. 
We propose and have applied a sampling-resampling approach to test the equality of a vector 
of average effects of alleles among groups. This approach is an extension of an approach 
suggested by Templeton et al. (1987) to test whether the average effects of the alleles at  a locus 
arc statistically significantly different from zero. The statistic we propose is : 
g(a) = c c (ajjk-oli.)', 
k 3  
where ajk is the average effect of the j t h  allele in the kth group and a?. is the average effect 
of the j t h  allele ignoring the groups. It is understood that the summation over the j alleles 
precedes the summation over the k groups. The distribution of this statistic is not known. The 
null distribution of the statistic may be approximated by calculating the value of the statistic 
from repeated sampling data under the null hypothesis (Efron, 1982). These repeated samples 
are generated from the sample of data to be tested by resampling without replacement from 
the data and allocating the observations randomly to the k groups. The overall genotype- 
phenotype relationship (ix.  the average effects of the alleles ignoring groups = ai.) and the size 
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of thc k groups is preserved in these analyses. If the value of g ( a )  from the data exceeds the 
percentile of the null distribution of g ( a )  determined by the desired significance level, one rejects 
the null hypothcsis that the average effects of the alleles at  this locus are the same among the 
k groups. 
For the present application. we wished to determine whether the average effects of the up0 
E= alleles are homogeneous among the parents and the youngest child from each family. We 
carriid out 5000 permutations of the data among groups before ar.y inference was made. We 
determined that 5000 permutations were sufficient for the distribu n of g(a )  to stabilize. For 
total cholesterol levels. the value of g ( a )  for the data is 0-091. The sal ple frequency distribution 
of y(a) for thc 5000 permutations of the data under the null hypo hesis is given in Figure 2 .  
The cut-off values that determine the loth,  5th and 1st percentile of this distribution are 0.537, 
0.647. 0.865. respectively. The statistic g(a) for the data does not exceed any of these 
significanc*e levels. Therefore. we infer that the average effects of the upo E alleles on total 
cholesterol levrls among the parents and the youngest child from each family are homogeneous. 
The average efiects of the npo E alleles on betalipoprotein and triglyceride levels were also not 
statisticdly significantly different between these two groups. 
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